---
layout: archive
title: "Publications & Presentations"
permalink: /publications/
author_profile: true
---

## Publications

1. **Liu W**, Higashikuni Y, Sata M. Chronobiological rhythms and artificial light at night in vascular physiology and pathology. Hypertens Res. 2024 Dec 04. [PDF](link-to-pdf)

2. Higashikuni Y, **Liu W**, Sata M. Nocturnal blood pressure and left ventricular hypertrophy in patients with diabetes mellitus. Hypertens Res. 2023 Dec 26. [PDF](link-to-pdf)

3. Higashikuni Y, **Liu W**, Sata M. Self-DNA sensing in cigarette smoke-induced vascular inflammation: the role of mitochondrial DNA release in vascular endothelial cells. Hypertens Res. 2023 Dec 19. [PDF](link-to-pdf)

4. Higashikuni Y, **Liu W**, Sata M. Not a small frog in a big pond: targeting bradykinin receptor B2 signaling in vascular smooth muscle cells for treatment of hypertension. Hypertens Res. 2023 Jul 28. [PDF](link-to-pdf)

5. **Liu W**, Higashikuni Y, Sata M. Optimizing antihypertensive therapy in patients with diabetes mellitus. Hypertens Res. 2023 Mar;46(3):797-800. [PDF](link-to-pdf)

6. Higashikuni Y, **Liu W**, Numata G, Tanaka K, Fukuda D, Tanaka Y, Hirata Y, Imamura T, Takimoto E, Komuro I, Sata M. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload. Circulation. 2023 Jan 24;147(4):338-355. [PDF](link-to-pdf)

7. **Liu, W.**, Higashikuni, Y., & Sata, M. (2022). Linking RNA dynamics to heart disease: The lncRNA/miRNA/mRNA axis in myocardial ischemiaâ€“reperfusion injury. Hypertension Research, 45(6), 1067-1069. [PDF](link-to-pdf)

8. Higashikuni, Y., **Liu, W.**, & Sata, M. (2022). Give a leg up: Screening for peripheral artery disease after acute myocardial infarction. Journal of Atherosclerosis and Thrombosis, 29(7), 989-991. [PDF](link-to-pdf)

9. Higashikuni, Y., **Liu, W.**, Obana, T., & Sata, M. (2021). Pathogenic basis of thrombo inflammation and endothelial injury in covid-19: Current findings and therapeutic implications. International Journal of Molecular Sciences, 22(21). [PDF](link-to-pdf)

10. **LIU Wenhao**, SHI Liu, LI Bin & LIU Yu. (2020). Non-diastolic mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Journal of Clinical Cardiology (12),1150-1154. [PDF](link-to-pdf)

11. LI Bin, **LIU Wenhao**, LI Xuesong, SHI Liu, GU Shaoke, ZHAO Yangyang & MAO Jingyuan. (2020). Using Speckle Tracking Imaging to Evaluate the Left Ventricular Systolic Function of Heart Failure with Preserved Ejection Fraction by Treatment of YangyinShuxin Decoction. Chinese Journal of Integrated Traditional And Western Medicine (09),1064-1069. [PDF](link-to-pdf)

12. **LIU Wenhao** & LI Bin. (2019). Rhabdomyolysis associated with bezafibrate therapy: a case report. Chinese Circulation Journal (08),828-829. [PDF](link-to-pdf)

## Presentations

1. **W. Liu**, Y. Higashikuni, T. Obana et al. "The DEAD-box RNA helicase Ddx41 contributes to adverse cardiac remodeling during pressure overload through modulation of RNA metabolism" AHA Scientific Sessions 2023, Nov 11-13, poster presentation.

2. **W. Liu**, Y. Higashikuni, T. Hirata et al. "The DEAD-box RNA helicase Ddx41 contributes to adverse cardiac remodeling induced by pressure overload through modulation of RNA metabolism" The 88th Annual Scientific Meeting of the Japanese Circulation Society (JCS2024) 2024, Mar 8-10, poster presentation.

3. **W. Liu**, Y. Higashikuni, T. Hirata et al. "Rbm15b is an RNA-binding protein that protects against adverse cardiac remodeling during pressure overload" The 88th Annual Scientific Meeting of the Japanese Circulation Society (JCS2024) 2024, Mar 8-10, poster presentation.

4. **W. Liu**, Y Higashikuni, Y Hirata, M Sata, T Matsumura, N Takeda. "N6-methyladenosine regulator Rbm15b protects against adverse cardiac remodeling under pressure overload" ISHR 2024, 2024, Dec 11-13, poster presentation.

5. **W. Liu**, Y Higashikuni, S. Tumurbaatar, A. Matsumoto, Y Hirata, M Sata, T Matsumura, N Takeda. "N6-methyladenosine regulator Rbm15b protects against adverse cardiac remodeling during pressure overload by modulating RNA methylation" ISHR 2025, 2025, May 11-14, poster presentation.

6. **W. Liu**, Y Higashikuni, S. Tumurbaatar, A. Matsumoto, Y Hirata, M Sata, T Matsumura, N Takeda. "N6-methyladenosine regulator Rbm15b protects against adverse cardiac remodeling under pressure overload through modulating RNA methylation" ESC Congress 2025, 2025, Aug 29-Sep 1, moderated poster presentation.
